A new publication dated July 17, 2026 presents research on Trhr1 reporter-labeled cells, relevant to the protirelin receptor pathway. The study, titled "Brain-wide mapping and region-specific cellular characterization of Trhr1 reporter-labeled cells in mice using VISoR imaging," appears in the journal Brain Structure & Function.
The paper describes brain-wide mapping and region-specific cellular characterization work conducted in mice using VISoR imaging technology. Trhr1 refers to the thyrotropin-releasing hormone receptor 1, the receptor through which protirelin, also known as thyrotropin-releasing hormone, exerts its effects.
This publication is indexed under PubMed ID 42467255. No efficacy or safety findings from the study have been summarized here beyond the title and journal of record. Readers interested in the full scope of the research, including methodology and results, are directed to the original publication for complete details.
Protirelin remains an approved compound. This brief reports only the existence and bibliographic details of this new publication as provided. For more background on protirelin, readers can consult the compound overview.